See more : Perpetual Energy Inc. (PMGYF) Income Statement Analysis – Financial Results
Complete financial analysis of Wacker Chemie AG (WKCMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Wacker Chemie AG, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Amarantus BioScience Holdings, Inc. (AMBS) Income Statement Analysis – Financial Results
- Shimmick Corporation Common Stock (SHIM) Income Statement Analysis – Financial Results
- Grenergy Renovables, S.A. (GRE.MC) Income Statement Analysis – Financial Results
- Eidai Kako Co.,Ltd. (7877.T) Income Statement Analysis – Financial Results
- Bridgeway National Corp. (BDGY) Income Statement Analysis – Financial Results
Wacker Chemie AG (WKCMF)
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silicas for use in construction, electronics, automotive, health, and renewable energy industries. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. The company was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.40B | 8.21B | 6.21B | 4.69B | 4.93B | 4.98B | 4.92B | 5.40B | 5.30B | 4.83B | 4.48B | 4.63B | 4.91B | 4.75B | 3.72B | 4.30B | 3.78B | 3.34B | 2.76B | 2.50B |
Cost of Revenue | 5.32B | 6.05B | 4.54B | 3.82B | 4.12B | 4.10B | 3.97B | 4.41B | 4.17B | 3.98B | 3.82B | 3.82B | 3.75B | 3.40B | 2.88B | 3.11B | -2.63B | -2.38B | -2.11B | -1.98B |
Gross Profit | 1.08B | 2.16B | 1.67B | 869.90M | 803.20M | 874.70M | 954.40M | 990.70M | 1.13B | 844.20M | 663.50M | 813.10M | 1.16B | 1.35B | 843.50M | 1.19B | 6.41B | 5.71B | 4.86B | 4.49B |
Gross Profit Ratio | 16.92% | 26.32% | 26.94% | 18.54% | 16.30% | 17.57% | 19.38% | 18.33% | 21.32% | 17.49% | 14.81% | 17.54% | 23.68% | 28.35% | 22.68% | 27.64% | 169.53% | 171.26% | 176.42% | 179.16% |
Research & Development | 184.10M | 178.40M | 164.20M | 156.60M | 173.30M | 164.60M | 153.10M | 183.40M | 175.30M | 183.10M | 173.80M | 174.50M | 172.90M | 165.10M | 164.00M | 163.20M | -152.50M | -152.30M | -146.90M | -150.60M |
General & Administrative | 177.50M | 183.20M | 158.80M | 139.50M | 145.60M | 159.70M | 148.50M | 147.30M | 134.00M | 123.70M | 111.70M | 119.20M | 124.00M | 113.30M | 95.50M | 109.50M | 94.10M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 337.50M | 342.50M | 297.60M | 290.60M | 314.50M | 303.50M | 292.40M | 321.60M | 314.20M | 280.60M | 272.00M | 280.20M | 280.80M | 269.60M | 246.40M | 257.60M | -233.50M | -223.90M | -211.20M | -206.10M |
SG&A | 540.40M | 525.70M | 456.40M | 430.10M | 460.10M | 463.20M | 440.90M | 468.90M | 448.20M | 404.30M | 383.70M | 399.40M | 404.80M | 382.90M | 341.90M | 367.10M | -233.50M | -223.90M | -211.20M | -206.10M |
Other Expenses | 4.80M | -10.30M | -3.00M | -2.00M | -1.80M | 7.20M | 9.80M | 8.80M | 0.00 | 0.00 | 0.00 | -54.60M | 0.00 | 0.00 | -27.80M | -6.10M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 729.30M | 693.80M | 617.60M | 584.70M | 631.60M | 607.10M | 562.90M | 614.70M | 592.50M | 406.90M | 471.60M | 455.90M | 551.60M | 543.70M | 689.40M | 540.10M | -386.00M | -376.20M | -358.10M | -356.70M |
Cost & Expenses | 6.05B | 6.74B | 5.15B | 4.41B | 4.76B | 4.71B | 4.53B | 5.03B | 4.76B | 4.39B | 4.29B | 4.28B | 4.30B | 3.95B | 3.57B | 3.65B | -3.02B | -2.75B | -2.46B | -2.34B |
Interest Income | 48.10M | 10.20M | 6.20M | 8.10M | 10.60M | 8.00M | 7.50M | 6.00M | 7.30M | 8.40M | 15.00M | 16.00M | 16.90M | 7.10M | 6.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 72.60M | 51.10M | 41.80M | 48.90M | 56.80M | 57.50M | 76.90M | 92.40M | 79.70M | 95.80M | 95.30M | 78.40M | 13.50M | 9.10M | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 418.70M | 402.10M | 404.20M | 403.50M | 554.90M | 540.40M | 590.40M | 618.00M | 575.40M | 599.00M | 564.40M | 528.80M | 501.00M | 429.90M | 579.90M | 407.30M | 351.90M | 330.00M | 351.20M | 344.00M |
EBITDA | 878.30M | 2.07B | 1.54B | 670.30M | 785.30M | 774.80M | 949.40M | 945.40M | 1.06B | 1.06B | 690.70M | 809.00M | 1.08B | 1.17B | 585.20M | 1.06B | 1.00B | 3.08B | 2.82B | 2.68B |
EBITDA Ratio | 13.72% | 24.90% | 24.61% | 15.39% | 31.15% | 18.58% | 20.40% | 20.09% | 20.00% | 22.25% | 16.29% | 17.46% | 22.04% | 24.67% | 19.73% | 24.55% | 89.05% | 92.43% | 102.16% | 107.14% |
Operating Income | 353.70M | 1.48B | 1.07B | 318.40M | 215.10M | 257.90M | 379.80M | 365.10M | 470.30M | 440.30M | 150.30M | 340.50M | 580.90M | 764.60M | 26.80M | 647.90M | 651.20M | 458.30M | 254.40M | 99.20M |
Operating Income Ratio | 5.52% | 17.99% | 17.27% | 6.79% | 4.37% | 5.18% | 7.71% | 6.76% | 8.88% | 9.12% | 3.36% | 7.35% | 11.83% | 16.10% | 0.72% | 15.07% | 17.22% | 13.73% | 9.23% | 3.96% |
Total Other Income/Expenses | 33.30M | 139.10M | 21.80M | -100.50M | -600.00K | 66.50M | -44.80M | -90.00M | -63.60M | -75.10M | -119.30M | -136.60M | -43.50M | -32.30M | -23.50M | -6.10M | -19.10M | -458.30M | -254.40M | -99.20M |
Income Before Tax | 387.00M | 1.62B | 1.09B | 217.90M | -591.20M | 324.40M | 335.00M | 264.80M | 406.70M | 365.20M | 31.00M | 193.20M | 567.40M | 732.30M | 3.30M | 641.80M | 632.10M | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 6.04% | 19.69% | 17.62% | 4.64% | -12.00% | 6.52% | 6.80% | 4.90% | 7.68% | 7.57% | 0.69% | 4.17% | 11.56% | 15.42% | 0.09% | 14.93% | 16.72% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 59.70M | 334.60M | 265.80M | 15.60M | 38.40M | 64.30M | 84.90M | 75.50M | 164.90M | 169.80M | 24.70M | 86.40M | 211.30M | 235.30M | 77.80M | -203.50M | 2.59B | 2.44B | 2.32B | 2.32B |
Net Income | 313.60M | 1.25B | 806.90M | 189.20M | -629.60M | 246.10M | 866.70M | 179.20M | 246.70M | 203.80M | 2.60M | 120.70M | 352.60M | 490.70M | -74.50M | 438.30M | 422.00M | 311.30M | 143.70M | 16.10M |
Net Income Ratio | 4.90% | 15.24% | 13.00% | 4.03% | -12.78% | 4.94% | 17.60% | 3.32% | 4.66% | 4.22% | 0.06% | 2.60% | 7.18% | 10.33% | -2.00% | 10.20% | 11.16% | 9.33% | 5.21% | 0.64% |
EPS | 6.31 | 25.18 | 16.24 | 3.81 | -12.67 | 4.95 | 17.45 | 3.61 | 4.97 | 4.10 | 0.05 | 2.43 | 7.10 | 9.88 | -1.50 | 8.84 | 8.49 | 6.46 | 2.90 | 53.31 |
EPS Diluted | 6.31 | 25.18 | 16.24 | 3.81 | -12.67 | 4.95 | 17.45 | 3.61 | 4.97 | 4.10 | 0.05 | 2.43 | 7.10 | 9.88 | -1.50 | 8.84 | 8.49 | 6.46 | 2.90 | 53.31 |
Weighted Avg Shares Out | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 44.33M | 52.15M |
Weighted Avg Shares Out (Dil) | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 44.33M | 52.15M |
Wacker Chemie: Upside In An Above-Average German Chemical Company
Wacker Chemie AG (WKCMF) Q1 2023 Results - Earnings Call Transcript
Wacker Chemie AG (WKCMF) Q4 2022 Earnings Call Transcript
Wacker Chemie: Heading Towards Turbulence
Wacker Chemie AG (WKCMF) Q3 2022 Earnings Call Transcript
Wacker Chemie AG (WKCMF) CEO Dr. Christian Hartel on Q2 2022 Results - Earnings Call Transcript
Wacker Chemie AG (WKCMF) CEO Christian Hartel on Q1 2022 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports